Regeneron’s high-dose Eylea hit with surprise FDA rejection over manufacturing hiccups zbecker Tue, 06/27/2023 – 16:44 More: Regeneron's high-dose Eylea hit with surprise FDA rejection over manufacturing hiccups Source: fierce
read moreAfter Emergent’s rise and fall, CEO Robert Kramer announces retirement kdunleavy Tue, 06/27/2023 – 15:11 More: After Emergent's rise and fall, CEO Robert Kramer announces retirement Source: fierce
read moreLilly forks over $2.4M to settle federal agency’s age discrimination lawsuit fkansteiner Tue, 06/27/2023 – 14:15 More: Lilly forks over .4M to settle federal agency's age discrimination lawsuit Source: fierce
read moreSkincare maker Galderma raises $1 billion through private placement, eyes long-delayed IPO zbecker Tue, 06/27/2023 – 11:10 More: Skincare maker Galderma raises billion through private placement, eyes long-delayed IPO Source: fierce
read moreAbbVie’s Imbruvica-Brukinsa patent suit may have merit, and BeiGene will likely settle: expert aliu Tue, 06/27/2023 – 10:53 More: AbbVie's Imbruvica-Brukinsa patent suit may have merit, and BeiGene will likely settle: expert Source: fierce
read moreUpdate on radiosensitising impact of SFX-01 when treating common soft tissue sarcoma condition More: Positive results for Evgen’s rhabdomyosarcoma therapy Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals